The Ohio Board of Pharmacy has recently published a number of guidance documents regarding recent law and rule changes that may impact your prescribing practices. TDDD Requirements for Controlled Substances: All locations that possess controlled substances are required to obtain licensure as a category III terminal distributor of dangerous drugs. Please be advised that this requirement takes effect on April 6, 2017. More information on this provision can be found by visiting: www.pharmacy.ohio.gov/TDDDcs . Office-Based Opioid Treatment: Effective August 4, 2017, all locations that treat more than 30 individuals for opioid dependence or addiction using a controlled substance are required to obtain a license as a terminal distributor of dangerous drugs with an office-based opioid treatment classification. Please be advised that there are some exemptions to this requirement. More information on this provision can be found by visiting: www.pharmacy.ohio.gov/OBOT . Effective April 1, 2017, all prescribers that possess compounded drugs or engage in the compounding of dangerous drugs (i.e. prescription drugs) must obtain a license as a terminal distributor of dangerous drugs (ORC 4729.541). More information on this provision can be found at: www.pharmacy.ohio.gov/prescribercompound .